|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-12-12
|
|
pubmed:abstractText |
To retrospectively investigate elevation of serum potassium when spironolactone (25 or 50 mg/day) and furosemide were administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) to patients with chronic heart failure for 12 months and occurrence of hyperkalemia and hypokalemia because of concomitant administration of spironolactone plus an ACE-I or ARB and furosemide.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0269-4727
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
603-10
|
|
pubmed:dateRevised |
2008-5-28
|
|
pubmed:meshHeading |
pubmed-meshheading:16336294-Adult,
pubmed-meshheading:16336294-Aged,
pubmed-meshheading:16336294-Aged, 80 and over,
pubmed-meshheading:16336294-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16336294-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16336294-Antihypertensive Agents,
pubmed-meshheading:16336294-Diuretics,
pubmed-meshheading:16336294-Drug Therapy, Combination,
pubmed-meshheading:16336294-Enalapril,
pubmed-meshheading:16336294-Female,
pubmed-meshheading:16336294-Furosemide,
pubmed-meshheading:16336294-Heart Failure,
pubmed-meshheading:16336294-Humans,
pubmed-meshheading:16336294-Hyperkalemia,
pubmed-meshheading:16336294-Losartan,
pubmed-meshheading:16336294-Male,
pubmed-meshheading:16336294-Middle Aged,
pubmed-meshheading:16336294-Potassium,
pubmed-meshheading:16336294-Sodium Potassium Chloride Symporter Inhibitors,
pubmed-meshheading:16336294-Spironolactone
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
|
|
pubmed:affiliation |
Department of Pharmacy, National Hospital Organization Osaka Medical Center, Japan. m-saito@onh.go.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
